Müller + Müller will become part of DWK upon closing in September 2020 and will continue to function under the same name and management.
DWK Life Sciences announced on August 26, 2020 that it has acquired Müller + Müller, a German manufacturer of primary packaging materials made of tubular glass for the pharmaceutical industry.
Under the terms of the acquisition, Müller + Müller will become part of DWK upon closing in September 2020, a DWK press release said. Müller + Müller will continue to function under the same name and will be managed by its current CEO, Florian Müller-Stauch.
“Acquiring the family business Müller + Müller is a significant strategic step for us in expanding our activities in the market for pharmaceuticals packaging,” explained CEO of DWK Life Sciences, Armin Reiche, in the press release. “We are not just investing in an important growth market here, but also in a company that boasts first class production technology and highly reliable products.”
“Driven by the high demand of the vaccine industry for vials, expansion of our production capacities is the next logical step,” added Müller-Stauch, in the press release. “We are delighted to have found a strong and reliable partner in DWK who will allow us to further develop our business.”
Source: DWK
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.